CKD patients exhibit profound alterations in drug metabolism and elimination pathways, with significant reductions in renal organic anion transporter (OAT1/OAT3) and organic cation transporter (OCT2) functionality, potentially precipitating unexpected bioaccumulation of herbal constituents and their metabolites. This evidence concerns the gene SLC22A6 and chronic kidney disease.